Adjuvant Pembrolizumab in Resected Stage III Melanoma Reply

被引：0
|
作者：
Eggermont, Alexander M. M. [1 ]
Robert, Caroline [1 ]
Suciu, Stefan [2 ]
机构：
[1] Gustave Roussy Canc Campus Grand Paris, Villejuif, France
[2] European Org Res & Treatment Canc Headquarters, Brussels, Belgium
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 379卷 / 06期
关键词：
HIGH-RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：593 / 595
页数：4
相关论文
共 50 条
  • [31] New Options for the Adjuvant Treatment of Cutaneous Melanoma?
    Weise, Amy M.
    Flaherty, Lawrence E.
    CURRENT ONCOLOGY REPORTS, 2014, 16 (11) : 1 - 6
  • [32] Neo-Adjuvant Therapy for Metastatic Melanoma
    Kuijpers, Anke M. J.
    van Akkooi, Alexander C. J.
    CANCERS, 2024, 16 (07)
  • [33] Prognostic impact of interhospital variation in adjuvant chemotherapy for patients with Stage II/III colorectal cancer: a nationwide study
    Arakawa, K.
    Kawai, K.
    Tanaka, T.
    Hata, K.
    Sugihara, K.
    Nozawa, H.
    COLORECTAL DISEASE, 2018, 20 (07) : O162 - O172
  • [34] Adjuvant therapy for patients with renal cell carcinoma following surgery: a focus on pembrolizumab
    Serzan, Michael
    Atkins, Michael B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (06) : 565 - 574
  • [35] Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma
    Turner, Robin M.
    Dieng, Mbathio
    Khanna, Nikita
    Nguyen, Mai
    Zeng, Jiaxu
    Nijhuis, Amanda A. G.
    Nieweg, Omgo E.
    Einstein, Andrew J.
    Emmett, Louise
    Lord, Sarah J.
    Menzies, Alexander M.
    Thompson, John F.
    Saw, Robyn P. M.
    Morton, Rachael L.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4561 - 4569
  • [36] Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review
    Meyers, B. M.
    Cosby, R.
    Quereshy, F.
    Jonker, D.
    CLINICAL ONCOLOGY, 2017, 29 (07) : 459 - 465
  • [37] Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study
    Babaei, Masoud
    Balavarca, Yesilda
    Jansen, Lina
    Lemmens, Valery
    van Erning, Felice N.
    van Eycken, Liesbet
    Vaes, Evelien
    Sjovall, Annika
    Glimelius, Bengt
    Ulrich, Cornelia M.
    Schrotz-King, Petra
    Brenner, Hermann
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (07) : 1480 - 1489
  • [38] The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanoma
    Ravichandran, Surya
    Nath, Neel
    Jones, David C.
    Li, Gabriel
    Suresh, Visakha
    Brys, Adam K.
    Hanks, Brent A.
    Beasley, Georgia M.
    Salama, April K. S.
    Howard, Brandon A.
    Mosca, Paul J.
    SURGICAL ONCOLOGY-OXFORD, 2020, 35 : 533 - 539
  • [39] Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
    Rawson, R., V
    Adhikari, C.
    Bierman, C.
    Lo, S. N.
    Shklovskaya, E.
    Rozeman, E. A.
    Menzies, A. M.
    van Akkooi, A. C. J.
    Shannon, K. F.
    Gonzalez, M.
    Guminski, A. D.
    Tetzlaff, M. T.
    Stretch, J. R.
    Eriksson, H.
    van Thienen, J., V
    Wouters, M. W.
    Haanen, J. B. A. G.
    Klop, W. M. C.
    Zuur, C. L.
    van Houdt, W. J.
    Nieweg, O. E.
    Ch'ng, S.
    Rizos, H.
    Saw, R. P. M.
    Spillane, A. J.
    Wilmott, J. S.
    Blank, C. U.
    Long, G., V
    van de Wiel, B. A.
    Scolyer, R. A.
    ANNALS OF ONCOLOGY, 2021, 32 (06) : 766 - 777
  • [40] Adjuvant Radiation Therapy in Macroscopic Regional Nodal Melanoma
    Fogarty, Gerald B.
    CANCERS, 2024, 16 (23)
12345